These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A summary of vinorelbine (Navelbine) safety data from North American clinical trials. Hohneker JA Semin Oncol; 1994 Oct; 21(5 Suppl 10):42-6; discussion 46-7. PubMed ID: 7973769 [TBL] [Abstract][Full Text] [Related]
25. Vinorelbine (Navelbine). A new semisynthetic vinca alkaloid. Krikorian A; Breillout F Onkologie; 1991 Feb; 14(1):7-12. PubMed ID: 2057177 [TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness analysis of three regimens using vinorelbine (Navelbine) for non-small cell lung cancer. Hillner BE; Smith TJ Semin Oncol; 1996 Apr; 23(2 Suppl 5):25-30. PubMed ID: 8610234 [TBL] [Abstract][Full Text] [Related]
27. Determination of vinorelbine (Navelbine) in tumour cells by high-performance liquid chromatography. Debal V; Morjani H; Millot JM; Angiboust JF; Gourdier B; Manfait M J Chromatogr; 1992 Oct; 581(1):93-9. PubMed ID: 1430011 [TBL] [Abstract][Full Text] [Related]
28. Oral vinorelbine (Navelbine) in the treatment of advanced breast cancer. Winer EP; Chu L; Spicer DV Semin Oncol; 1995 Apr; 22(2 Suppl 5):72-8; discussion 78-9. PubMed ID: 7740337 [TBL] [Abstract][Full Text] [Related]
29. A study of the electrochemical oxidation of Navelbine. Brett AM; Grazina MM; Macedo TR; Oliveira C; Raimundo D J Pharm Biomed Anal; 1993 Mar; 11(3):203-6. PubMed ID: 8518318 [TBL] [Abstract][Full Text] [Related]
30. [Occurrence of gastric phytobezoar after chemotherapy with vinorelbine]. Ferrero JM; François E; Frenay M; Namer M Presse Med; 1993 Apr; 22(13):638. PubMed ID: 8511105 [No Abstract] [Full Text] [Related]
31. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer. Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230 [TBL] [Abstract][Full Text] [Related]
32. [Localized epidermal necrolysis after intravenous injection of vinorelbine]. Misery L; Perrot JL; Vergnon JM; Boucheron S; Emonot A; Claudy A Presse Med; 1992 Dec 19-26; 21(44):2153. PubMed ID: 1297136 [No Abstract] [Full Text] [Related]
33. Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors. Rowinsky EK; Noe DA; Trump DL; Winer EP; Lucas VS; Wargin WA; Hohneker JA; Lubejko B; Sartorius SE; Ettinger DS J Clin Oncol; 1994 Sep; 12(9):1754-63. PubMed ID: 8083697 [TBL] [Abstract][Full Text] [Related]
34. High-performance liquid chromatographic determination of navelbine in human plasma and urine. Nicot G; Lachatre G; Marquet P; Bonnaud F; Vallette JP; Rocca JL J Chromatogr; 1990 Jun; 528(1):258-66. PubMed ID: 2384562 [No Abstract] [Full Text] [Related]
35. Phase II study of navelbine in advanced renal cell carcinoma. Canobbio L; Boccardo F; Guarneri D; Calabria C; Decensi A; Curotto A; Martorana G; Giuliani L Eur J Cancer; 1991; 27(6):804-5. PubMed ID: 1829928 [No Abstract] [Full Text] [Related]
36. Vinorelbine therapy in a hemodialyzed patient. Rollino C; Milongo R; Schaerer R; Cordonnier D Nephron; 1992; 61(2):232-3. PubMed ID: 1630554 [No Abstract] [Full Text] [Related]
37. Determination of navelbine and desacetylnavelbine in biological fluids by high-performance liquid chromatography. Jehl F; Debs J; Herlin C; Quoix E; Gallion C; Monteil H J Chromatogr; 1990 Jan; 525(1):225-33. PubMed ID: 2338443 [No Abstract] [Full Text] [Related]
38. [Navelbine (vinorelbine): a review of its antitumor activity and toxicity in clinical studies]. Niitani H Gan To Kagaku Ryoho; 1999 Sep; 26(10):1495-507. PubMed ID: 10500542 [TBL] [Abstract][Full Text] [Related]
39. [Efficacy of vinorelbine monotherapy in advanced and metastatic breast cancer]. Suehisa H; Aogi K; Hara F; Takabatake D; Takashima S; Ohsumi S; Takashima S; Komatsubara K Gan To Kagaku Ryoho; 2008 Oct; 35(10):1709-12. PubMed ID: 18931573 [TBL] [Abstract][Full Text] [Related]